RAC1 and lung carcinoma: Particularly for lung cancer, Rac1 has been established as a bona fide effector of tyrosine kinase receptors (TKRs) that play prominent roles in disease initiation and progression, including EGFR (Caino et al., 2012; Murillo et al., 2018).